Related Experiment Video
Updated: Jul 16, 2026

Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
[Ocular manifestations in Proteus syndrome]
M Sánchez-López1, R Martínez-Fernández, A Santamaría-Carro
1Servicio de Oftalmología de Hospital de Cruces, Vizcaya, España. mariasanlo@terra.es
This case report details ocular manifestations in Proteus syndrome, a rare genetic disorder. Findings include retinal dysgenesia, optic nerve hypoplasia, strabismus, and high myopia, highlighting the need for comprehensive eye exams in affected individuals.
Area of Science:
- Ophthalmology
- Genetics
- Dermatology
Background:
- Proteus syndrome is a rare hamartomatous disorder characterized by asymmetric overgrowth and various anomalies.
- Congenital disfiguring malformations often result from multifactorial etiologies.
- Ocular manifestations in Proteus syndrome are not well-documented.
Observation:
- A patient with Proteus syndrome presented with significant ocular abnormalities.
- Retinal examination revealed retinal dysgenesia, pigmentary abnormalities, and optic nerve hypoplasia.
- Additional findings included strabismus and high myopia.
Findings:
- The case highlights a spectrum of ocular malformations associated with Proteus syndrome.
- Specific findings include retinal dysgenesis, optic nerve hypoplasia, strabismus, and high myopia.
- This underscores the potential for diverse visual impairments in individuals with Proteus syndrome.
Implications:
- A thorough craniofacial and ophthalmic examination is crucial for patients with Proteus syndrome.
- Systematic ocular studies are needed to better understand the incidence and range of eye abnormalities.
- Improved medical care and early detection of visual impairments can benefit patients with this complex disorder.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Photoreceptors and Visual Pathways
Glaucoma: Overview
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury III: Clinical Manifestations

